The PHS 2009-2 Omnibus Solicitation of the NIH, CDC, FDA, and ACF for SBIR/STTR Grant Applications and SF 424 (R&R) Application Guide for SBIR/STTR Grant Applications are now available.
The due dates are April 5, August 5, and December 5.
AIDS and AIDS-related applications are due May 7, September 7, 2009, and January 7, 2010.
The SBIR Phase II Bridge Award is intended to augment previously funded NIH-wide SBIR Phase II projects that require additional funding in order to achieve key technical and regulatory milestones along the path toward commercialization.
Have you recently submitted an SBIR or STTR proposal to the NIH? Don’t forget to check the status of your grant throughout the review process.
What is the status of your grant?
To which study section was it assigned?
Who are the SRG panel members?
(Rosters for previous study sections can be found here)
To which Institute/Center was it assigned?
If assigned to an inappropriate study section of Institute/Center a change can be requested. But only if you keep track of your grant’s status.
Six hundred people traveled to Atlanta’s Omni Hotel this week to attend the National Institutes of Health’s very successful 10th Annual SBIR/STTR Conference. This conference, celebrating the Silver Anniversary of SBIR inception, drew entrepreneurs, biotech business owners, researchers, university faculty and licensing staff, state representatives, and investors from around the nation.
More than fifty NIH and CDC staff members were on hand to conduct one-on-one guidance sessions, workshops, and submission instruction sessions. University licensing and tech transfer associates, investors, and previous NIH SBIR/STTR awardees gave advice from their perspectives in sessions and during networking events. From a pool of submissions, fifty companies had been selected to present their SBIR/STTR findings via a poster session; this honor allowed the previous recipients to demonstrate how SBIR/STTR funding had helped advance their research.
For 2008, the NIH’s Omnibus SBIR/STTR solicitation still has the August 5th and December 5th submission dates for Non-AIDS related topics and September 7th and January 7th for AIDS related topics.
The National Cancer Institute (NCI) announced the launch of their pilot Bridge Award Program and is seeking applications from small business concerns (SBC). This program is designed to address the funding gap known as the "valley of death" between the end of a Phase II award and product commercialization for those developing cancer therapies or cancer imaging technologies. Previously funded Phase II applicants in this space are encouraged to apply. Award requests of $1M per year for up to 3 years are allowed. While those with matching funds will be given priority, a match from a third party investor or strategic partner is not required. This program is designed to attract third party investment in this capital intensive phase of commercialization. For more information on the program please click here.